Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Feb 13, 2022 7:38pm
172 Views
Post# 34425043

RE:RE:RE:CBD, cannibal market, outlook USA.

RE:RE:RE:CBD, cannibal market, outlook USA.I'd say, and I have many times the hiring of the CEO was clearly strategic timing to coincide with a turnaround...I don't think a takeover was in the works at his hiring nor do I think a proposal would be warmly received by the board....a takeover would be hostile because the valuation is so low one could accumulate 51% at a lower value than what majority deem fair value or acceptable. I get why investors are Leary of medipharm but the unfortunate events contributing to this decline were necessary to pivot the business to one with sustained growth and profitability ...investors are leaving Labs for dead... Despite the extreme negative sentiment right now I'm incredibly bullish and my position is approaching 500 000 shares....so what some money manger is dumping shares....these guys are just as prone to making wrong calls as anyone...theres no insider leak...anyone who makes big money on stocks finds promising company's in a growing market with a clean balance sheet and buys the he'll outta them when everyone is selling.
<< Previous
Bullboard Posts
Next >>